Century Therapeutics, Inc. (IPSC)
NASDAQ·Healthcare·Biotechnology
$2.19
-2.67%
Mkt Cap $194.78M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | -$62.50K | — | — | -$0.28 | -$0.25 | +10.71% | — | — |
| Q4 2025 Nov 13, 2025 | -$83.33K | — | — | -$0.39 | -$0.32 | +17.95% | — | — |
| Q3 2025 Aug 14, 2025 | $25.00K | — | — | -$0.38 | -$0.38 | +0.00% | — | — |
| Q2 2025 May 15, 2025 | $41.29M | $109.16M | +164.37% | -$0.31 | $0.89 | +387.10% | — | — |
| Q1 2025 Mar 19, 2025 | $49.55M | $4.17M | -91.58% | -$0.45 | -$0.43 | +4.44% | — | — |
| Q4 2024 Nov 5, 2024 | $440.00K | $791.00K | +79.77% | -$0.46 | -$0.37 | +19.57% | — | — |
| Q3 2024 Aug 8, 2024 | $430.00K | $771.00K | +79.30% | -$0.50 | -$0.38 | +24.00% | — | — |
| Q2 2024 May 9, 2024 | $210.00K | $855.00K | +307.14% | -$0.50 | -$0.45 | +10.00% | — | — |
| Q1 2024 Mar 14, 2024 | $1.67M | $268.00K | -83.94% | -$0.56 | -$0.49 | +12.50% | — | — |
| Q4 2023 Nov 9, 2023 | $1.32M | $148.00K | -88.76% | -$0.53 | -$0.55 | -3.77% | — | — |
| Q3 2023 Aug 9, 2023 | $1.14M | $99.00K | -91.33% | -$0.54 | -$0.56 | -3.70% | — | — |
| Q2 2023 May 11, 2023 | $1.47M | $1.72M | +16.71% | -$0.53 | -$0.53 | +0.00% | — | — |
| Q1 2023 Mar 16, 2023 | $2.00M | $521.00K | -73.99% | -$0.59 | -$0.55 | +6.78% | — | — |
| Q4 2022 Nov 10, 2022 | $1.08M | $2.22M | +105.45% | -$0.59 | -$0.53 | +10.17% | — | — |
| Q3 2022 Aug 11, 2022 | $1.34M | $1.40M | +4.33% | -$0.50 | -$0.54 | -8.00% | — | — |
| Q2 2022 May 16, 2022 | $10.00M | $1.06M | -89.42% | -$0.45 | -$0.66 | -46.67% | — | — |
| Q1 2022 Mar 17, 2022 | — | — | — | -$0.46 | -$0.24 | +47.83% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.40 | -$0.48 | -20.00% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$0.42 | -$1.93 | -359.52% | — | — |
| Q2 2021 Jun 21, 2021 | — | — | — | — | -$0.37 | — | — | — |